William 'Jamie' T.

Co-founder & CTO at Diamond Therapeutics

William 'Jamie' T. has a diverse work experience in the field of neuroengineering and neuromodulation. William 'Jamie' currently holds the position of Professor of BME at the University of Alabama at Birmingham, where they are part of the faculties of Neuroengineering, Health Professions, Physical Medicine, and Rehabilitation.

Prior to this, Jamie co-founded and served as the Managing Member of the private neurotechnology company IST, specializing in the development of noninvasive bioelectronic and ultrasonic neuromodulation devices. William 'Jamie' has also co-founded Diamond Therapeutics, where they served as the Chief Investment Officer.

Jamie's previous roles include being an Associate Professor at Arizona State University, where they conducted research on noninvasive neuromodulation methods and neural interfaces. William 'Jamie' also served as the Founding Director of the WearTech Applied Research Center, a private-public partnership aimed at accelerating the commercialization of wearable technologies.

Additionally, they have a background in industry, having co-founded Thync and serving as the Chief Scientific Officer. William 'Jamie' was also an Assistant Professor at Virginia Tech Carilion School of Medicine and Research Institute, where they led a neuro-engineering research team focused on developing and optimizing neuromodulation methods and systems.

Jamie's career started with their involvement in the company SynSonix, where they secured contracts for the development of ultrasonic neuromodulation technology for pain control. William 'Jamie' also served as an Assistant Professor of Neurobiology and Bioimaging at Arizona State University, where their groundbreaking research on pulsed ultrasound stimulation of brain circuits contributed to the field of noninvasive focal brain stimulation and neuromodulation.

Overall, Jamie brings a wealth of expertise and experience in the field of neuroengineering and neuromodulation, with a strong emphasis on noninvasive techniques and the commercialization of innovative technologies.

William 'Jamie' T. began their education at the University of Alabama at Birmingham in 1991 and completed their Bachelor of Science degree in an unspecified field of study in 1998. William 'Jamie' then pursued further education at the same institution, obtaining a Ph.D. in Behavioral Neuroscience from 1998 to 2003. Following this, Jamie went on to Harvard University, where they completed a Postdoctoral Fellowship in Neuroscience from 2003 to 2006.

Location

Birmingham, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Diamond Therapeutics

Diamond Therapeutics is a psychedelic drug development company based in Toronto. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort — maximizingthe positive impact better drugs can have on the global mental health crisis.


Headquarters

Toronto, Canada

Employees

1-10

Links